ESR1 and hepatocellular carcinoma: Previous studies have reported that M0 macrophages are correlated with decreased survival time in estrogen receptor-positive breast cancer patients (Bense et al., 2017) and hepatocellular cancer patients (Hsiao et al., 2019).